Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,605 | 1 | 84.3% |
| Food and Beverage | $670.69 | 29 | 15.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| FUJIFILM Medical Systems USA, Inc. | $3,605 | 1 | $0 (2018) |
| ABBVIE INC. | $206.91 | 10 | $0 (2024) |
| Medtronic, Inc. | $126.06 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $78.85 | 5 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $70.48 | 4 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $36.49 | 2 | $0 (2024) |
| PENTAX of America, Inc. | $28.95 | 1 | $0 (2024) |
| Braintree Laboratories, Inc. | $27.17 | 1 | $0 (2023) |
| Laborie Medical Technologies Corp. | $25.97 | 1 | $0 (2024) |
| Olympus America Inc. | $20.92 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $308.96 | 16 | ABBVIE INC. ($97.37) |
| 2023 | $146.17 | 7 | ABBVIE INC. ($81.16) |
| 2022 | $168.65 | 3 | Medtronic, Inc. ($126.06) |
| 2021 | $35.59 | 2 | Ironwood Pharmaceuticals, Inc ($35.59) |
| 2018 | $3,616 | 2 | FUJIFILM Medical Systems USA, Inc. ($3,605) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: LIVER DISEASE | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Immunology | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Immunology | ||||||
| 04/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/20/2024 | Olympus America Inc. | EndoClot PHS (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Endotherapy | ||||||
| 02/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2024 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $25.97 | General |
| 02/11/2024 | PENTAX of America, Inc. | INSPIRA (Device), PENTAX Medical, PENTAX Medical | Food and Beverage | Cash or cash equivalent | $28.95 | General |
| Category: Gastroenterology | ||||||
| 01/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Gastroenterology | ||||||
| 09/15/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Immunology | ||||||
| 08/25/2023 | Braintree Laboratories, Inc. | SUFLAVE (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: GI COLON PREP | ||||||
| 08/23/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: IMMUNOLOGY | ||||||
| 02/27/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.57 | General |
| Category: GI | ||||||
| 01/31/2023 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/08/2022 | Medtronic, Inc. | ENDOFLIP (Device) | Food and Beverage | In-kind items and services | $126.06 | General |
| Category: Motility Testing | ||||||
| 10/06/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 912 | 9,131 | $1.3M | $258,847 |
| 2022 | 21 | 783 | 8,580 | $1.2M | $233,893 |
| 2021 | 21 | 816 | 7,059 | $1.1M | $210,499 |
| 2020 | 22 | 818 | 892 | $789,711 | $87,706 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 18 | 6,603 | $231,035 | $112,971 | 48.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 161 | 161 | $289,800 | $32,617 | 11.3% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 12 | 832 | $116,200 | $21,756 | 18.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 50 | 498 | $49,800 | $18,092 | 36.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 50 | 286 | $42,900 | $13,754 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 115 | 115 | $46,000 | $8,106 | 17.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 112 | 113 | $152,550 | $6,963 | 4.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 72 | 72 | $144,000 | $6,621 | 4.6% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 29 | 29 | $20,300 | $4,587 | 22.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 45 | $22,500 | $4,422 | 19.7% |
| 91038 | Prolonged monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 13 | 13 | $6,500 | $4,042 | 62.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 23 | 32 | $12,800 | $3,152 | 24.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 30 | 30 | $24,000 | $2,895 | 12.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $16,000 | $2,823 | 17.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $12,000 | $2,513 | 20.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 13 | 66 | $16,500 | $2,421 | 14.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $22,500 | $2,379 | 10.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 62 | $12,400 | $2,313 | 18.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $20,800 | $1,755 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 26 | $7,800 | $1,532 | 19.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,100 | $891.86 | 7.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 23 | $6,900 | $847.66 | 12.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 16 | $3,200 | $773.76 | 24.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 21 | $2,100 | $450.24 | 21.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 13 | 13 | $1,300 | $171.12 | 13.2% |
About Dr. Michael Heacock, M.D
Dr. Michael Heacock, M.D is a Gastroenterology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1699932327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Heacock, M.D has received a total of $4,276 in payments from pharmaceutical and medical device companies, with $308.96 received in 2024. These payments were reported across 30 transactions from 13 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($3,605).
As a Medicare-enrolled provider, Heacock has provided services to 3,329 Medicare beneficiaries, totaling 25,662 services with total Medicare billing of $790,945. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Asheville, NC
- Active Since 05/20/2008
- Last Updated 10/23/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1699932327
Products in Payments
- ESD - Core Endoscopy (Device) $3,605
- ENDOFLIP (Device) $126.06
- SKYRIZI (Biological) $77.98
- CREON (Drug) $60.47
- STELARA (Biological) $60.05
- Linzess (Drug) $59.16
- LINZESS (Drug) $57.78
- VOQUEZNA (Drug) $36.49
- INSPIRA (Device) $28.95
- SUFLAVE (Drug) $27.17
- RINVOQ (Biological) $22.00
- EndoClot PHS (Device) $20.92
- XIFAXAN (Drug) $18.97
- TREMFYA (Drug) $18.80
- RESMETIROM (Drug) $15.71
- ZEPOSIA (Drug) $14.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Asheville
Adam Zivony, M.d, M.D
Gastroenterology — Payments: $179,865
Dr. Brian Garvin, Md, MD
Gastroenterology — Payments: $130,620
Jessica Fisher, M.d, M.D
Gastroenterology — Payments: $5,868
Charles Shrode, Md, MD
Gastroenterology — Payments: $5,452
Dr. William Harlan, M.d, M.D
Gastroenterology — Payments: $5,312
Dr. David May, M.d, M.D
Gastroenterology — Payments: $3,411